New Drugs Flashcards
1
Q
carbamazepine: class
A
anti-epileptic
2
Q
carbamezepine: MOA
A
- suppresses high frequency neuronal discharge in and around seizure foci
- mechanism: delayed recovery of socium channels from their inactivated state
3
Q
carbamezepine: indication
A
- epilepsy: tonic clonic, simple partial, complex partial
- first drug of choice of partial seizures
- bipolar disorder
- trigeminal and glossopharyngeal neuralgias
4
Q
carbamezepine: SE
A
- CNS effects: visual disturbance, ataxia, vertigo, HA
- photosensitivity rxns
5
Q
carbamezepine: ADRs
A
- leukopenia
- thrombocytopenia
- aplastic anemia
- birth defects: spina bifida
- hypo-osmolarity: so inhibits excretion of water and promotes secretion of ADH
- problem for patients with HF
- suicidal thoughts
- Stevens Johnson Syndrome
6
Q
carbamezepine: nursing implications
A
- contraindications: pregnancy (only use if the benefits of seizure control outweight the risks to the fetus); bone marrow suppression
- causes fewer ADRs than other anti-epileptics (phenytoin and phenobarbital)
- minimize CNS effects by start therapy at low doses and give largest dose at bedtime
- d/c if experience hematologic effects but only if WBC is below 3000
- do CBC
- administer with meals to prevent GI upset
- monitor Na levels
- can tx mild dermatologic effects with prednisone or an antihistamine
- do not drink alcohol, grapefruit juice
- do not d/c abruptly
7
Q
phenytoin: class
A
- anti-epileptic
8
Q
phenytoin: MOA
A
- causes selective inhibition of Na channels
- slows recovery of Na channels from the inactive state back to the active state, so entry of Na into neuron is inhibited, so APs are suppressed
9
Q
phenytoin: Indication
A
- seizures: partial seizures, tonic clonic seizures
- cardiac dysrhythmias
10
Q
phenytoin: SEs
A
- CNS effects: sedation, nystagmus, diplopia
- gingival hyperplasia
- hypotension
- cardiac dysrhythmias
11
Q
phenytoin: ADRs
A
- toxic epidermal necrolysis
- stevens johnson syndrome
- fetus: cleft palate, heart malformations, fetal hydantoin syndrome, bleeding tendency
- suicidal thoughts
- acute hepatic failure
- agranulocytosis
- aplastic anemia
12
Q
phenytoin: nursing implications
A
- contraindications: alcohol intolerance, heart block, bradycardia
- caution in pregnant women: only use if safer alternatives are not effective
- give folic acid; good oral hygiene to prevent gingival hyperplasia
- to prevent neonatal bleeding, give prophylactic vitamin K to mom 1 month before/during delivery and to baby after
- inject slowly by IV to prevent dysrhythmias
- do not take w/in 2-3 hours of antacids
- take at same time daily
- give with food to prevent GI upset
- do not d/c abruptly
13
Q
valproic acid: indication
A
- anti-epileptic
14
Q
valproic acid: MOA
A
- suppression of high frequency neuronal firing thru blockade of Na channels
- suppress Ca influex
- augment inhibitory effects of GABA
15
Q
valproic acid: indication
A
- seizure: first line for partial and generalized seizure
- bipolar disorder
- migraine
16
Q
valproic acid: SE
A
- GI effects: n/v
- rash
- weight gain
- tremor
17
Q
valproic acid: ADRs
A
- hepatotoxicity
- pancreatitis
- teratogen: spina bifida, impairment of cognitive fcn
- hyperammonemia
- suicidal thoughts
- hypothermia
18
Q
valproic acid: nursing implications
A
- contraindications: hepatic impairment, mitochondrial disorders, pregnancy
- take with food to minimize GI upset
- evaluate liver fcn at baseline and during therapy
- use at lowest effective dosage
- MUST use effective contraception and should take folic acid supplements
- inform pt about S/S of liver toxicity and pancreatitis
- do not d/c abruptly
19
Q
gabapentin: class
A
- anti-epileptic
- mood stabilizer
20
Q
gabapentin: MOA
A
- unknown
- analog of GABA but does not directly affect GABA receptors, but may enhance the release of GABA
21
Q
gabapentin: indication
A
- adjunctive therapy for partial seizures
- postherpetic neuralgia
- off label: neuropathic pain, migraine, fibromyalgia, hot flashes
22
Q
gabapentin: SE
A
- CNS: somnolence, dizziness, ataxia, fatigue
- peripheral edema
23
Q
gabapentin: ADRs
A
- suicidal thoughts
- rhabdomyolysis
24
Q
gabapentin: nursing implications
A
- use w/ caution in pregnant women, b/c the effects have not been determined
- do not take w/in 2 hours of an antacid
- can be administered w/o regard to meals
- do not d/c abruptly
25
levetiracetam: class
* anti-epileptic
26
levetiracetam: indications
* myoclonic seizures (if over 12 yo)
* partial onset seizures (in those over 4 yo)
* primary generalized tonic clonic seizures (in those over 6 yo)
* unlabeled: migraine, bipolar
27
levetiracetam: SEs
* drowsiness
* asthenia
* CNS: agitation, anxiety, depression, hallucinations, depersonalization
28
levetiracetam: ADRs
* suicidal thoughts
* agranulocytosis
* Stevens johnson syndrome
* toxic epidermal necrolysis
29
levetiracetam: nursing implications
* contraindicated: breast feeding
* safety has not been established in pregnancy
* max dose is 3000 mg/day
* do not d/c abruptly
30
ethosuximide: class
* anti-epileptic
31
ethosuximide: MOA
* suppresses neurons in the thalamus that are responsible for generating absence seizures
32
ethosuximide: indications
* absence seizures (first line)
* (Better tolerated than valproic acid, but works to the same effectiveness)
33
ethosuximide: SE
* CNS: drowsiness, dizziness, lethargy
* n/v
34
ethosuximide: ADRs
* SLE
* leukopenia
* aplastic anemia
* Stevens Johnson syndrome
* inc freq of seizures
* suicidal thoughts
35
ethosuximide: nursing implications
* contraindications: children under 3 yo
* administer with food to prevent GI upset
* vry long half life, so can take 1x or 2x per day
* do not d/c abruptly
* avoid alcohol
* avoid during pregnancy
36
lithium: class
* mood stabilizer
37
lithium: indications
* bipolar disorder (for manic episodes)
* prophylaxis against manic and depressive disorders
38
lithium: SEs
* when lithium is above therapeutic range:
* hand tremor
* GI upset
* thirst
* muscle weakness
* when lithium at therapeutic range:
* fatigue
* muscle weakness
* HA
* confusion
* tremor
* polyuria
* hypothyroidism/goiter
39
lithium: ADRs
* teratogenesis
* renal toxicity
* seizures
40
lithium: nursing implications
* contraindicated: severe CV/renal dz, dehydrated pts, breast feeding
* DO NOT use during 1st trimester of pregnancy
* should have a negative pregnancy test before work
* NARROW THERAPEUTIC RANGE: 0.5-1.5
* kidney fcn tests, thyroid fcn tests
* can take a beta blocker to reduce tremor
* maintain adequate hydration
* administer w/ food to prevent GI upset
41
haloperidol: class
* 1st gen anti psychotic
42
haloperidol: MOA
* Alters the effects of dopamine in the CNS.
* Also has anticholinergic and alpha-adrenergic blocking activity.
43
haloperidol: indications
* schizophrenia
* acute psychosis
* Tourette's Syndrome
44
haloperidol: SEs
* anticholinergic effects
* sedation
* hypoTN
* extrapyramidal rxns (acute dystonia, parkinsonism, akathisia)
* neuroendocrine effects: galactorrhea, gynecomastia, menstrual irregularities
45
haloperidol: ADRs
* serious dysrhythmias
* esp long QT
* seizures
* agranulocytosis
* neuroleptic malignant syndrome
46
haloperidol: nursing implications
* contraindications: pts who are comatose, severely depressed, pts w/ Parkinson's, bone marrow depression, severe hypoTN and HTN
* also avoid in pts with risk factors for torsades de pointes (like hypokalemia, hypomagnesemia, bradycardia, long QT, history of dysrhythmias, MI) or those taking drugs that cause long QT
* report any signs of EPS
* to prevent anticholinergic effects: void before using, drink water and eat sugarfree candy, inc fluids/fibers, do not exercise outside in hot temps
* inform pts about possible orthostatic hypoTN
* take at night at 1st to prevent this
* watch for sore throat/fever (early signs of agranulocytosis)
* do not use alcohol
* do not d/c abruptly
47
Levodopa/Carbidopa: class
* anti-parkinsonian
48
Levodopa/Carbidopa: MOA
* carbidopa enhances effects of levodopa
* carbidopa has no therapeutic effects on its own, but it inhibits decarboxylation of levodopa in the intestine and peripheral tissues, so makes more levodopa available in the CNS
* does not prevent conversion of levodopa to dopamine in the brain, b/c carbidopa does not cross BBB
* levodopa is converted to dopamine in the brain and used as a NT
49
Levodopa/Carbidopa: Indications
* Parkinson's Dz
50
Levodopa/Carbidopa: SEs
* n/v (but admin w/ carbidopa helps with this)
* involuntary movements
* postural hypoTN
* dysrhythmias
* psychosis: hallucinations, vivid dreams, paranoid ideation
* CNS: anxiety, agitation, insomnia, nightmares, impulse control (alcohol, sex, gambling)
* darker colored sweat/urine
51
Levodopa/Carbidopa: ADRs
* malignant melanoma
* hemorrhage
* GI perforation
* pancreatitis
52
Levodopa/Carbidopa: nursing implications
* contraindications: glaucoma, MAOIs, melanoma, undiagnosed skin lesions
* can take w/ food to reduce n/v, but this also dec the amt of levodopa that will be absorbed, so avoid if possible
* avoid high protein meals
* if pt experiences involuntary mvmts, then can administer amantidine
* sit/stand up slowly to prevent orthostatic hypoTN
* watch for any changes in skin lesions and report
* Inform patient that harmless darkening of saliva, urine, or sweat may occur.
53
disulfiram: class
* alcohol abuse therapy
54
disulfiram: MOA
* disrupts alcohol metabolism by causing irreversible inhibition of aldehyde dehydrogenase
* so if alcohol is ingested, acetaldehyde will accumulate to toxic levels, producing unpleasant and potentially harmful effects
55
disulfiram: indications
* helps alcoholics avoid drinking by causing unpleasant effects if alcohol is ingested
56
disulfiram: SEs
* drowsiness
* skin rxn
57
disulfiram: ADRs
* hepatotoxicity
* acetaldehyde syndrome--dangerous
* mild: n/v, flushing, constipation, HA, sweating, thirst, chest pain, hypoTN, blurred vision
* severe: respiratory depression, CV collapse, dysrhythmias, MI, CHF, convulsions, death
58
disulfiram: nursing implications
* contraindications: CV dz, psychosis, use of alcohol, lactation
* make sure to educate pts that consuming any amount of alcohol (as little as 7 mL) can cause a severe, possibly fatal, rxn
* minimum duration of tx is 3 mos
* administer at bedtime to reduce drowsiness
* immediately report any signs of hepatotoxicity
59
Lithium Toxicity S/S
* polydipsia
* slurred speech
* fine hand tremors
* + oliguria,
* N/V,
* hypotension,
* muscle weakness,
* diarrheas